Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing type
4
Filing date
Oct 1, 2020
Updated
Oct 2, 2020 ยท 7:51 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership